Zevra Therapeutics D
D
ZVRA
9.51000
USD
-0.29
(-2.91%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
31,028
الربح لكل سهم
1
العائد الربحي
-
P/E
10
حجم السوق
564,739,757
العنوان: Zevra Therapeutics
القطاع: الرعاية الصحية
الصناعة: Biotechnology
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.